That is a concern, and I think, again, if you read the legislation, it doesn't stop at those two drugs. I think that's one of the big things we need to keep reminding ourselves about. It contemplates, within a year, going well beyond that, and so if you get into a situation in which hundreds or thousands of medications are covered, then employers are absolutely going to start asking themselves, “Why should I be still in the game?”
We work really hard to educate them on the value of the programs that they're offering their employees. As I said, it tends to be more flexible and much broader than what they might get on a public plan, but that pressure and those questions will start if this bill, two years down the road, comes to fruition.
Again, that's not the vision that we heard from the minister today, so I think that disconnect is what's giving us pause.